Related Experiment Video

Updated: Jun 6, 2026

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

Myocardial revascularization reverses adverse outcome in non-ST-elevation acute coronary syndromes complicated by

Luís Raposo1, Carlos Aguiar, Jorge Ferreira

  • 1Servçgo de Cardiologia, Hospital de Santa Cruz, Carnaxide, Portugal. lfor.md@gmail.com

Revista Portuguesa De Cardiologia : Orgao Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology
|November 12, 2010
PubMed

Insights

Congestive heart failure (CHF) worsens outcomes in non-ST-elevation acute coronary syndromes (NSTE-ACS). Myocardial revascularization significantly improves prognosis for NSTE-ACS patients with CHF, but not for those without it.

Area of Science:

  • Cardiology
  • Cardiovascular Medicine
  • Interventional Cardiology

Background:

  • Congestive heart failure (CHF) is a significant negative prognostic factor in patients with non-ST-elevation acute coronary syndromes (NSTE-ACS).
  • Understanding the impact of interventions on outcomes in this high-risk population is crucial.

Purpose of the Study:

  • To determine the effect of myocardial revascularization on the prognosis of patients with NSTE-ACS, particularly those with CHF.
  • To assess whether revascularization modifies the adverse prognostic impact of CHF in NSTE-ACS.

Main Methods:

  • Retrospective analysis of 648 patients admitted with NSTE-ACS without cardiogenic shock.
  • Propensity score-adjusted regression models were used to evaluate the impact of coronary revascularization on outcomes.
  • Outcomes included 6-month mortality and non-fatal myocardial infarction (MI).

Main Results:

  • CHF was present in 14.5% of patients and was an independent predictor of adverse 6-month outcomes (mortality and death/re-MI).
  • Myocardial revascularization significantly improved prognosis in NSTE-ACS patients with CHF (adjusted HR 0.31; p=0.008).
  • Revascularization did not significantly impact prognosis in NSTE-ACS patients without CHF (adjusted HR 1.37; p=0.4), with a significant interaction noted between revascularization and CHF presence (p=0.021).

Conclusions:

  • Clinical manifestations of CHF in NSTE-ACS patients are a strong predictor of adverse medium-term outcomes.
  • Myocardial revascularization can significantly modify this adverse prognosis, offering a therapeutic benefit specifically for NSTE-ACS patients with CHF.
Abstract

More Related Videos

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...